MYT1L | Myelin transcription factor 1-like | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
MZF1 | Myeloid zinc finger 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR0B1 | Nuclear receptor subfamily 0, group B, member 1 | Cancer-related genes Disease related genes Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NR1D1 | Nuclear receptor subfamily 1, group D, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1D2 | Nuclear receptor subfamily 1, group D, member 2 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H2 | Nuclear receptor subfamily 1, group H, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H3 | Nuclear receptor subfamily 1, group H, member 3 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H4 | Nuclear receptor subfamily 1, group H, member 4 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1I3 | Nuclear receptor subfamily 1, group I, member 3 | Cytoskeleton related proteins Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
NR2C1 | Nuclear receptor subfamily 2, group C, member 1 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2C2 | Nuclear receptor subfamily 2, group C, member 2 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
NR2F1 | Nuclear receptor subfamily 2, group F, member 1 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR3C2 | Nuclear receptor subfamily 3, group C, member 2 | Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR4A3 | Nuclear receptor subfamily 4, group A, member 3 | Cancer-related genes Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
NR6A1 | Nuclear receptor subfamily 6, group A, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
OSR1 | Odd-skipped related transciption factor 1 | Predicted intracellular proteins Transcription factors
| | | | | Mixed |
OSR2 | Odd-skipped related transciption factor 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OVOL1 | Ovo-like zinc finger 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OVOL2 | Ovo-like zinc finger 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PATZ1 | POZ (BTB) and AT hook containing zinc finger 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PEG3 | Paternally expressed 3 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PLAGL1 | Pleiomorphic adenoma gene-like 1 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PLAGL2 | Pleiomorphic adenoma gene-like 2 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
POGZ | Pogo transposable element with ZNF domain | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PPARD | Peroxisome proliferator-activated receptor delta | FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PPARG | Peroxisome proliferator-activated receptor gamma | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PRDM1 | PR domain containing 1, with ZNF domain | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PRDM10 | PR domain containing 10 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PRDM13 | PR domain containing 13 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Not detected |
PRDM14 | PR domain containing 14 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PRDM15 | PR domain containing 15 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Mixed |
PRDM2 | PR domain containing 2, with ZNF domain | Enzymes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PRDM4 | PR domain containing 4 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PRDM5 | PR domain containing 5 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Mixed |
PRDM6 | PR domain containing 6 | Enzymes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PRDM8 | PR domain containing 8 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PRDM9 | PR domain containing 9 | Enzymes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
PRKRIR | Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
RARA | Retinoic acid receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
RARB | Retinoic acid receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
RARG | Retinoic acid receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
RC3H2 | Ring finger and CCCH-type domains 2 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
RERE | Arginine-glutamic acid dipeptide (RE) repeats | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
REST | RE1-silencing transcription factor | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |